Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-062693
Filing Date
2006-12-04
Accepted
2006-12-04 15:56:41
Documents
1
Period of Report
2006-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4804
  Complete submission text file 0001209191-06-062693.txt   6760
Mailing Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078
Business Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078 44 1382 207506
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111
Business Address 415-362-4022
DELEAGE JEAN (Reporting) CIK: 0001198323 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 061254252